E Fund Management (HK)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
1,288
+1,013
+368% +$218K 0.11% 122
2026
Q1
$59.8K Buy
275
+225
+450% +$49.9K 0.03% 169
2025
Q4
$11.3K Buy
50
+33
+194% +$7.52K ﹤0.01% 198
2025
Q3
$3.94K Buy
+17
New +$3.46K ﹤0.01% 156

Other funds holding ABBV

E Fund Management (HK)'s ABBV Position: Q2 2026 in Review

E Fund Management (HK) increased its AbbVie (ABBV) stake by 368% in Q2 2026, buying an estimated $218K and bringing the position to 1,288 shares worth $324K. The position accounts for 0.11% of the portfolio, ranked #122.

E Fund Management (HK) first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 1,758 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • E Fund Management (HK) held 1,288 shares of AbbVie worth $324K as of Q2 2026.
  • E Fund Management (HK) bought 1,013 AbbVie shares in Q2 2026, an estimated $218K.
  • AbbVie made up 0.11% of E Fund Management (HK)'s portfolio in Q2 2026, its #122 holding.
  • E Fund Management (HK) first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 1,758 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.